Corestate Capital (CCAP) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
15 Jun, 2026Executive summary
Continued execution of deleveraging strategy and operational stabilization, focusing on non-core asset disposals and development of Hannover Leasing as the core platform.
Revenues and gains declined to €5.1m in Q1 2026 from €8.7m in Q1 2025; EBITDA at €-4.7m versus €-2.2m year-over-year.
Net profit was €-9.5m (Q1 2025: €-8.8m); adjusted net profit at €-8.7m (Q1 2025: €-7.9m); EPS unchanged at €-0.1.
Assets under management fell to €7.5bn from €8.5bn at year-end 2025.
Financial highlights
Equity ratio dropped to -2.5% from 0.5% at year-end 2025.
Cash and cash equivalents decreased to €13.2m from €18.4m sequentially.
Net debt increased to €165.9m from €160.1m at year-end 2025.
Asset disposals in 2023 and 2024 totaled €68.2m; 2026 asset sales include €11.1m from Giessen.
Outlook and guidance
Deleveraging strategy to continue through 2026, with all net proceeds from asset disposals allocated to note repayments.
Extension of Senior Notes maturities supports orderly asset disposal program.
Hannover Leasing remains the operational core and focus for future development.
Latest events from Corestate Capital
- Revenue and EBITDA rebounded, with asset disposals and debt extension supporting stabilization.CCAP
Q4 202527 Apr 2026 - Significant losses and deleveraging mark a challenging transition to a holding structure.CCAP
Q3 20255 Jan 2026 - Revenue and EBITDA fell, but asset sales and liquidity support ongoing deleveraging.CCAP
Q2 20255 Sep 2025 - Restructuring nearly complete; focus shifts to asset sales and deleveraging amid market headwinds.CCAP
Q4 20248 Aug 2025 - Revenue up, profits down; asset sales and debt repayment drive 2025 strategy.CCAP
Q1 202517 Jun 2025 - Net loss, lower equity, and delayed asset sales mark Corestate's ongoing restructuring.CCAP
Q3 202413 Jun 2025 - EBITDA loss narrowed and asset sales accelerated, but AUM and equity ratio declined.CCAP
Q2 202413 Jun 2025 - Losses narrowed and asset sales progressed, but liquidity remains a key challenge.CCAP
Q1 202413 Jun 2025